Sign up to read this article for FREE!
After signing up, you'll start to receive regular news updates from us.
EuropaBio Response to EU Commission’s Nationalisation of Approval for the Cultivation of GM Crops
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
Commission’s Nationalisation of Approval for the Cultivation of GM Crops
- EuropaBio, Brussels, July 13, 2010
This afternoon EuropaBio provided industry’s initial reactions to Commissioner Dalli’s announcement of the
Commission’s proposal to nationalise the authorisation of cultivation of GM crops.
Commenting on the proposal, EuropaBio Secretary General, Nathalie Moll, said: “EuropaBio recognised President Barroso’s commitment early on to develop a smart, sustainable and inclusive economy and we were also encouraged by the Commission’s goal of embracing responsible European innovation across all sectors. Furthermore, we appreciated the vision put forward by the Commission of enabling the EU member states to move forward on the issue of GM crop cultivation at their own pace. Central to this vision must be permitting those member states and their farmers who wish to embrace the benefits of GM crops the freedom to do so.”
Consequently, industry is disappointed that today’s proposal does not appear to provide a means of delivering this vision in that it disables rather than enables the application of beneficial and rigorously tested
agricultural biotech products and technologies. We strongly believe that for the proposal to be workable it must be science-based, proportionate in its recommendations and non-discriminatory to those farmers that
wish to choose to grow the crops that work best for them. Without due respect for these fundamental principles, the resulting policy will be detrimental to the overall sustainability and success of the European
agricultural sector as a whole.
EuropaBio Director for Agricultural Biotechnology, Carel du Marchie Sarvaas, explained: “These proposals appear to give carte blanche to ban safe and approved GM crops in any country or region regardless of the
needs or wishes of their farmers. In addition, the proposals will inject further legal uncertainty for those farmers that do wish to grow these crops. The upshot is that even as we contemplate a future fraught with the
challenges of globalisation, climate change, food insecurity and shortage of natural resources, we will be denying our farmers the ability to use cutting edge technologies, already available to their counterparts
outside the EU, to help them to deal with these same challenges”.
EuropaBio and its members remain committed to applying their expertise towards providing sustainable and beneficial products and technologies giving European farmers and consumers a greater choice in what they
grow, buy and eat.
For further information please contact:
Carel du Marchie Sarvaas
Director, Agricultural Biotech, EuropaBio
Tel: +32 477 537 541; Email: c.dmsarvaas@europabio.org
Joanna Dupont Inglis
Communications Manager, EuropaBio
Tel: +32 2 739 11 84; GSM: +32 476 60 71 35 Email: j.dupont@europabio.org
EuropaBio is the European Association for Bioindustries, bringing together bioscience companies from all fields of research and development, testing, manufacturing and distribution of biotechnology products. It has 66 corporate and 7 associated members, 4 BioRegions and 22 National Biotechnology Associations representing some 1800 small and medium sized enterprises.
http://www.europabio.org
http://www.choiceforeurope.com/en/
- EuropaBio, Brussels, July 13, 2010
This afternoon EuropaBio provided industry’s initial reactions to Commissioner Dalli’s announcement of the
Commission’s proposal to nationalise the authorisation of cultivation of GM crops.
Commenting on the proposal, EuropaBio Secretary General, Nathalie Moll, said: “EuropaBio recognised President Barroso’s commitment early on to develop a smart, sustainable and inclusive economy and we were also encouraged by the Commission’s goal of embracing responsible European innovation across all sectors. Furthermore, we appreciated the vision put forward by the Commission of enabling the EU member states to move forward on the issue of GM crop cultivation at their own pace. Central to this vision must be permitting those member states and their farmers who wish to embrace the benefits of GM crops the freedom to do so.”
Consequently, industry is disappointed that today’s proposal does not appear to provide a means of delivering this vision in that it disables rather than enables the application of beneficial and rigorously tested
agricultural biotech products and technologies. We strongly believe that for the proposal to be workable it must be science-based, proportionate in its recommendations and non-discriminatory to those farmers that
wish to choose to grow the crops that work best for them. Without due respect for these fundamental principles, the resulting policy will be detrimental to the overall sustainability and success of the European
agricultural sector as a whole.
EuropaBio Director for Agricultural Biotechnology, Carel du Marchie Sarvaas, explained: “These proposals appear to give carte blanche to ban safe and approved GM crops in any country or region regardless of the
needs or wishes of their farmers. In addition, the proposals will inject further legal uncertainty for those farmers that do wish to grow these crops. The upshot is that even as we contemplate a future fraught with the
challenges of globalisation, climate change, food insecurity and shortage of natural resources, we will be denying our farmers the ability to use cutting edge technologies, already available to their counterparts
outside the EU, to help them to deal with these same challenges”.
EuropaBio and its members remain committed to applying their expertise towards providing sustainable and beneficial products and technologies giving European farmers and consumers a greater choice in what they
grow, buy and eat.
For further information please contact:
Carel du Marchie Sarvaas
Director, Agricultural Biotech, EuropaBio
Tel: +32 477 537 541; Email: c.dmsarvaas@europabio.org
Joanna Dupont Inglis
Communications Manager, EuropaBio
Tel: +32 2 739 11 84; GSM: +32 476 60 71 35 Email: j.dupont@europabio.org
EuropaBio is the European Association for Bioindustries, bringing together bioscience companies from all fields of research and development, testing, manufacturing and distribution of biotechnology products. It has 66 corporate and 7 associated members, 4 BioRegions and 22 National Biotechnology Associations representing some 1800 small and medium sized enterprises.
http://www.europabio.org
http://www.choiceforeurope.com/en/
